Muscular dystrophy biotech aTyr Pharma sets terms for $75 million IPO

Muscular dystrophy biotech aTyr Pharma sets terms for $75 million IPO

4/27/15

Related Post

2015.10.08 Osong BioExcellence & BioTech Fair
views 173
지난 10월 8일 충북 오송에서 열린   2015 Osong BioExcellence & BioTech Fair에서 Dr. Thomas Neenan 이 Creating Value from an Academic Pipeline 이란 주제로 바이오콘 pipeline...
ATyr Pharma Raises $76M Round to Advance Physocrin...
views 145
ARS 전문 바이오벤쳐기업 ATyr Pharma가 7천 6백만 달러 (약 800억원)의 투자유치에 성공했다는 소식입니다. 첨부한 PDF 파일을 참조하시기 바랍니다. ...
aTyr Pharma Announces Encouraging Phase 1b/2 Resul...
views 116
Thu, Mar 31, 2016, 2:09AM EDT - US Markets open in 7 hrs and 21 mins  aTyr Pharma Announces Encouraging Phase 1b/2 Results for Resolaris™ in its First...
0 Comments

Leave a reply

Your email address will not be published. Required fields are marked *

*

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2010-2017 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar